Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Liver Neoplasms × tislelizumab × Clear all

Phase

Status

Unknown 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 8 Esophageal Squamous Cell Carcinoma 6 Carcinoma, Non-Small-Cell Lung 6 Stomach Neoplasms 4 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Recurrence 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Advanced Solid Tumors 3 Advanced Solid Tumor 3 Squamous Cell Carcinoma of Head and Neck 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 NSCLC 1 Multiple Pulmonary Nodules 1 Mid-low Rectal Cancer 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1

Interventions

Sorafenib 39 Bevacizumab 14 Oxaliplatin 13 Leucovorin 9 Fluorouracil 9 Doxorubicin 9 Radiofrequency Ablation 8 Hepatectomy 8 Gemcitabine 8 Cisplatin 8 Capecitabine 8 Radiosurgery 7 pembrolizumab 6 Nivolumab 6 Irinotecan 6 Drug Therapy 6 Cryosurgery 6 Carboplatin 6 Talaporfin 5 Mitomycin 5 spartalizumab 4 Melphalan 4 Everolimus 4 Erlotinib Hydrochloride 4 Embolization, Therapeutic 4 Electroporation 4 aldesleukin 3 Surveys and Questionnaires 3 Sunitinib 3 Sirolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05532319 2025-12-30

FRONT-1

Guangxi Medical University

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡